Moderna Inc reported 4.75B in Sales Revenues for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Acadia Pharmaceuticals ACAD:US $ 115.47M 15.29M
Acorda Therapeutics ACOR:US $ 31.05M 8.52M
Agios Pharmaceuticals AGIO:US $ 5.58M 4.75M
Alnylam Pharmaceuticals ALNY:US $ 224.82M 11.56M
Amgen AMGN:US $ 6594M 356M
Arrowhead Research ARWR:US $ 32.41M 119.39M
Biogen BIIB:US $ 2589.1M 57.3M
Biomarin Pharmaceutical BMRN:US $ 533.8M 14.44M
Bluebird Bio BLUE:US $ 1.52M 0.43M
Esperion Therapeutics ESPR:US $ 18.84M 5K
Gilead Sciences GILD:US $ 6260M 330M
GlaxoSmithKline GSK:LN 6929M 2851M
Intercept Pharmaceuticals ICPT:US $ 71.76M 16.82M
IONIS PHARMACEUT IONS:US $ 141.92M 298.09M
Mirati Therapeutics MRTX:US $ 5.36M 4.65M
Puma Biotechnology PBYI:US $ 59.52M 13.78M
Regeneron Pharmaceuticals REGN:US $ 2857.2M 107.9M
Sangamo Biosciences SGMO:US $ 29.38M 1.15M
Sarepta Therapeutics SRPT:US $ 233.49M 22.66M
Seattle Genetics SGEN:US $ 497.5M 71.04M
Ultragenyx Pharmaceutical RARE:US $ 89.34M 9.41M
United Therapeutics UTHR:US $ 466.9M 5M
Vertex Pharmaceuticals VRTX:US $ 2196.2M 98.7M
YTE INCY:US $ 911.4M 178.16M